Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Shuji Kubo

Dual-Vector Prodrug Activator Gene Therapy Using Retroviral Replicating Vectors

Cancer Gene Therapy

English

In VivoCorrection With Recombinant Adenovirus of 4-Hydroxyphenylpyruvic Acid Dioxygenase Deficiencies in StrainIIIMice

English

Related publications

Challenges in Vector and Trial Design Using Retroviral Vectors for Long-Term Gene Correction in Hematopoietic Stem Cell Gene Therapy

English

Replicating Retroviral Vectors Mediating Continuous Production and Secretion of Therapeutic Gene Products From Cancer Cells

English

278. Challenges in the Manufacturing of Retroviral Gene Therapy Vectors

English

Q Vectors, Bicistronic Retroviral Vectors for Gene Transfer

English

Supplemental Guidance on Testing for Replication-Competent Retrovirus in Retroviral Vector-Based Gene Therapy Products and During Follow-Up of Patients in Clinical Trials Using Retroviral Vectors

English

Gene Therapy Using Retrovirus Vectors: Vector Development and Biosafety at Clinical Trials

Uirusu. Journal of virology

Medicine

2015

English

Genetic Mobility and Instability of Retroviral Vector in Vector Producer Cells for Gene Therapy

English

E- Vectors: Development of Novel Self-Inactivating and Self-Activating Retroviral Vectors for Safer Gene Therapy.

English

Yaba-Like Disease Virus: An Alternative Replicating Poxvirus Vector for Cancer Gene Therapy

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Shuji Kubo

Dual-Vector Prodrug Activator Gene Therapy Using Retroviral Replicating Vectors

In VivoCorrection With Recombinant Adenovirus of 4-Hydroxyphenylpyruvic Acid Dioxygenase Deficiencies in StrainIIIMice

Related publications

Challenges in Vector and Trial Design Using Retroviral Vectors for Long-Term Gene Correction in Hematopoietic Stem Cell Gene Therapy

Replicating Retroviral Vectors Mediating Continuous Production and Secretion of Therapeutic Gene Products From Cancer Cells

278. Challenges in the Manufacturing of Retroviral Gene Therapy Vectors

Q Vectors, Bicistronic Retroviral Vectors for Gene Transfer

Supplemental Guidance on Testing for Replication-Competent Retrovirus in Retroviral Vector-Based Gene Therapy Products and During Follow-Up of Patients in Clinical Trials Using Retroviral Vectors

Gene Therapy Using Retrovirus Vectors: Vector Development and Biosafety at Clinical Trials

Genetic Mobility and Instability of Retroviral Vector in Vector Producer Cells for Gene Therapy

E- Vectors: Development of Novel Self-Inactivating and Self-Activating Retroviral Vectors for Safer Gene Therapy.

Yaba-Like Disease Virus: An Alternative Replicating Poxvirus Vector for Cancer Gene Therapy